Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (SHA:600329)
37.47
-0.68 (-1.78%)
Nov 20, 2026, 3:00 PM CST
| Market Cap | 24.55B -20.2% |
| Revenue (ttm) | 4.67B -13.1% |
| Net Income | 895.67M -75.0% |
| EPS | 1.16 -75.0% |
| Shares Out | 770.09M |
| PE Ratio | 32.24 |
| Forward PE | 27.96 |
| Dividend | 4.68 (12.49%) |
| Ex-Dividend Date | Jul 10, 2026 |
| Volume | 5,063,679 |
| Open | 38.04 |
| Previous Close | 38.15 |
| Day's Range | 37.16 - 38.08 |
| 52-Week Range | 33.83 - 48.20 |
| Beta | 0.36 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Oct 31, 2026 |